Advanced Biomed Faces Delisting Concerns

Ticker: ADVB · Form: 8-K · Filed: Jul 24, 2025 · CIK: 1941029

Advanced Biomed INC. 8-K Filing Summary
FieldDetail
CompanyAdvanced Biomed INC. (ADVB)
Form Type8-K
Filed DateJul 24, 2025
Risk Levelhigh
Sentimentbearish

Sentiment: bearish

Topics: delisting, compliance, listing-rule

TL;DR

Advanced Biomed might get delisted - stock could be in trouble.

AI Summary

Advanced Biomed Inc. filed an 8-K on July 24, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filing indicates a potential issue with the company's compliance with stock exchange listing requirements as of July 18, 2025. The company is incorporated in Nevada and its principal executive offices are located in Tainan City, Taiwan.

Why It Matters

This filing signals potential delisting from a stock exchange, which could significantly impact the liquidity and trading of Advanced Biomed Inc.'s shares.

Risk Assessment

Risk Level: high — A notice of delisting directly threatens the company's ability to remain publicly traded, posing a significant risk to investors.

Key Numbers

Key Players & Entities

FAQ

What specific listing rule or standard has Advanced Biomed Inc. failed to satisfy?

The filing does not specify the exact rule or standard that Advanced Biomed Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on July 18, 2025.

What is the company's principal executive office address?

The company's principal executive offices are located at No. 689-85 Xiaodong Road, Yongkang District, Tainan City, Taiwan.

In which U.S. state is Advanced Biomed Inc. incorporated?

Advanced Biomed Inc. is incorporated in Nevada.

What is the Commission File Number for Advanced Biomed Inc.?

The Commission File Number for Advanced Biomed Inc. is 001-42548.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 24, 2025 regarding Advanced Biomed Inc. (ADVB).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing